Ontology highlight
ABSTRACT:
SUBMITTER: Wills VS
PROVIDER: S-EPMC4677368 | biostudies-other | 2015 Dec
REPOSITORIES: biostudies-other
ACS medicinal chemistry letters 20151028 12
Studies of triazole bisphosphonates have resulted in identification of a potent inhibitor of geranylgeranyl diphosphate synthase (IC50 = 45 nM) with very good selectivity for this enzyme over farnesyl diphosphate synthase (IC50 = 28 μM). This compound also potently disrupts geranylgeranylation and induces cytotoxicity in human myeloma cells at submicromolar levels, suggesting that it may serve as a lead compound for treatment of malignancies characterized by excessive protein secretion. ...[more]